User login
SAN DIEGO – Greater intake of soy isoflavones has been associated with lower prevalence of asthma in recent studies, but results from the placebo-controlled, federally funded SOYA (Study of Soy Isoflavones in Asthma) trial to assess soy supplements’ impact on asthma control showed that lung function didn’t improve with increased soy isoflavone intake. In a video interview at the annual meeting of the American Academy of Allergy, Asthma, and Immunology, Dr. Lewis Smith of Northwestern University, Chicago, discusses the study's negative results, and what may have been behind the findings.
SAN DIEGO – Greater intake of soy isoflavones has been associated with lower prevalence of asthma in recent studies, but results from the placebo-controlled, federally funded SOYA (Study of Soy Isoflavones in Asthma) trial to assess soy supplements’ impact on asthma control showed that lung function didn’t improve with increased soy isoflavone intake. In a video interview at the annual meeting of the American Academy of Allergy, Asthma, and Immunology, Dr. Lewis Smith of Northwestern University, Chicago, discusses the study's negative results, and what may have been behind the findings.
SAN DIEGO – Greater intake of soy isoflavones has been associated with lower prevalence of asthma in recent studies, but results from the placebo-controlled, federally funded SOYA (Study of Soy Isoflavones in Asthma) trial to assess soy supplements’ impact on asthma control showed that lung function didn’t improve with increased soy isoflavone intake. In a video interview at the annual meeting of the American Academy of Allergy, Asthma, and Immunology, Dr. Lewis Smith of Northwestern University, Chicago, discusses the study's negative results, and what may have been behind the findings.
AT 2014 AAAAI ANNUAL MEETING
